Glaukos (NYSE:GKOS – Free Report) had its price objective hoisted by Wells Fargo & Company from $83.00 to $103.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an overweight rating on the medical instruments supplier’s stock. A number of other equities analysts have also recently weighed in on the […]
Glaukos (NYSE:GKOS – Get Free Report) issued its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.56) by ($0.07), Briefing.com reports. The company had revenue of $82.40 million during the quarter, compared to the consensus estimate of $81.00 million. Glaukos had a negative […]
Glaukos (NYSE:GKOS) Earns Buy Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Glaukos (NYSE:GKOS – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, February 21st. Analysts expect Glaukos to post earnings of ($0.56) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link. Glaukos Stock Performance NYSE:GKOS opened […]
Allspring Global Investments Holdings LLC raised its position in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 17.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,827 shares of the medical instruments supplier’s stock after buying an additional 270 shares during […]